Objective: This study aimed to compare video-assisted informed consent with standard informed consent regarding anxiety, recall of procedure-related risks, procedural experience, and patients' perceptions of the informed consent process among patients undergoing thyroid fine-needle aspiration biopsy.Materials and Methods: This randomized controlled trial included 76 patients who underwent thyroid fine-needle aspiration biopsy. Patients were randomly assigned to video-assisted informed consent (n=38) and standard informed consent (n=38) groups. Data were collected using a demographic information form, the Beck Anxiety Inventory, and a structured questionnaire including recall of procedure-related risks, procedure experience, and patients' assessments of the informed consent process. Descriptive and comparative statistical methods appropriate to the variables' distributional characteristics and data type were used to evaluate the data. Results: The groups were similar in terms of sociodemographic characteristics. The median Beck Anxiety Inventory score was 6.00 (1.00–15.00) in the standard informed consent group and 5.50 (1.25–11.75) in the video-assisted group, with no statistically significant difference between the groups (U=724.0; p=0.988). There was no statistically significant difference between the groups in terms of recalling individual risks associated with the procedure (p>0.05). Procedure experience also showed no significant difference between the groups (p=0.854), with 73 out of 76 participants (96.1%) reporting that the procedure was as expected or better than expected.Conclusion: No statistically significant differences were found between the video-assisted and standard informed consent groups in anxiety scores, recall of procedure-related risks, procedural experience, or patient-reported assessments of the informed consent process.Keywords: Audiovisual aids, informed consent, patient education, thyroid nodule
19 May 2026 in Journal of Health Sciences and Medicine
Aims: This study aimed to evaluate and compare the technical success, clinical efficacy, and safety of N-butyl cyanoacrylate (NBCA) versus coil embolization in the endovascular management of acute hemorrhage.Methods: Between July 2024 and November 2025, 33 patients who underwent embolization for acute bleeding, including abdominal wall, gastrointestinal, renal, soft tissue, and tumoral hemorrhages, were retrospectively analyzed. The study population consisted of the NBCA group (n=16) and the coil group (n=17). Technical success was defined as the complete angiographic occlusion of the target vessel and cessation of contrast extravasation. Clinical success was defined as symptomatic improvement during hospitalization without the need for re-intervention, recurrent bleeding, or mortality. Procedural times, success rates, and complication rates were compared between the two groups.Results: Technical success was achieved in 100% of cases in both groups. Clinical success rates were 87.5% (14/16) in the NBCA group and 76.5% (13/17) in the coil group. Embolization time was significantly shorter in the NBCA group (10.6±3.4 min) than in the coil group (22.0±15.4 min) (p=0.0079). Re-bleeding rates were 12.5% for the NBCA group and 23.5% for the coil group, showing no significant difference (p=0.407). No major complications or non-target embolization events occurred in either group.Conclusion: No statistically significant differences were observed in clinical success, re-bleeding, or complication rates between the NBCA and coil groups in our cohort. However, the use of NBCA was associated with significantly shorter embolization times, which may offer a potential advantage in the management of acute arterial bleeding.
23 September 2026 in Irish Journal of Medical Science (1971 -)